Trademarkia Logo

Canada

C$
Trademark Search in Canada
SYNLOGIC DESIGN

View On IC.GC.CA

SYNLOGIC DESIGN
REGISTERED

on 10 Aug 2021

Last Applicant/ Owned by

SYNLOGIC INC.

200 Sidney Street, Suite 320Cambridge , MA 02139

US

Serial Number

1858077 filed on 18th Sept 2017

Registration Number

TMA1104780 registered on 10th Aug 2021

Registration expiry Date

10th Aug 2031

SYNLOGIC DESIGN

Trademark usage description

pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of gastrointestina Read More

Vienna Information

15 . 9 . 1

Electrical equipmentMatériel électrique

15 . 9 . 18

Integrated circuits, computer chipsCircuits intégrés, puces électroniques

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

Classification Information

Class [005]
Pharmaceuticals and herbicides

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [010]
Pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of gastrointestinal diseases and disorders, inflammatory diseases and disorders, namely arthritis, rheumatoid arthritis, inflammatory bowel diseases, inflammatory connective tissue diseases, vasculitis, synovitis and inflammatory pelvic diseases, autoimmune diseases and disorders, cancer and respiratory diseases and disorders; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of neurological diseases and disorders, namely Parkinson's disease, Alzheimer's disease, Huntington's disease, dementia, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of infectious diseases and disorders, namely influenza, cholera, malaria, meningitis, measles, hepatitis A, B, and C, West Nile virus and dermatological diseases and disorders, namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of genitourinary diseases and disorders, namely urological diseases and disorders; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of diseases and disorders namely, cardiovascular, cardiopulmonary, cardio-renal and renal diseases and disorders and hepatic diseases and disorders; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of genetic diseases and disorders, namely phenylketonuria, muscular dystrophy, Turner syndrome, cystic fibrosis; pharmaceutical preparations and therapeutic agents in the nature of engineered and biologically-modified microbes for the treatment of metabolic diseases and disorders, namely growth and thyroid disorders, cycle disorders, diabetes, metabolic syndrome, obesity, weight loss and weight management;

Classification kind code

11

Mark Details

Serial Number

1858077

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 15
on 6th Nov 2019		Correspondence Created
Submitted for opposition 67
on 16th Jul 2019		Agent Name Changed
Submitted for opposition 48
on 20th Jun 2019		Agent Changed
Submitted for opposition 67
on 20th Jun 2019		Agent Name Changed
Submitted for opposition 12
on 13th May 2019		Extension of Time
Submitted for opposition 22
on 25th Oct 2018		Search Recorded
Submitted for opposition 20
on 25th Oct 2018		Examiner's First Report
Submitted for opposition 31
on 21st Sept 2017		Formalized
Submitted for opposition 1
on 20th Sept 2017		Created
Submitted for opposition 30
on 18th Sept 2017		Filed